David specializes in patent prosecution in the areas of life science, chemistry and biotechnology.

David’s areas of technical focus include:

• Protein purification, spectroscopy, chromatography, immunoassays, ELISAs, titration, and DNA sequencing.
• Performing ELISAs, immunoassays, PCR and RT-PCR, agarose gel electrophoresis, plasmid mapping, and restriction enzyme digests.

Prior to joining Hamilton, Brook, Smith and Reynolds, David was a quality control biochemist at Novavax, Inc. in Gaithersburg, Maryland. At this position, he led the pre-validation and validation of new PicoGreen standard operating procedure (SOP). He also performed polymerase chain reactions (PCRs), pH analysis, single radial immunodiffusion (SRID) assays, and enzyme-linked immunosorbent assays (ELISAs) on samples of vaccine components to assure they complied with quality control standards.

While at Georgetown University for his Master’s degree in Biomedical Science, David was awarded the Academic Excellence Medal for graduating with high honors. He also served as a staff member and note editor for the American Journal of Law and Medicine while obtaining his J.D. at Boston University School of Law.

• Patents
• IP Litigation
• Trademarks
• Trademark Opposition and Cancellation Proceedings
• Trade Secrets

• Biotechnology and Life Sciences
• Biologics and Immunotherapies
• Pharmaceuticals
• Chemistry
• Medical Devices

• Marymount University, B.S. in Biology, magna cum laude
• Georgetown University, M.S. in Biomedical Science in Biochemistry, Awarded Academic Excellence Medal
• Boston University School of Law, J.D.

Articles

• Supreme Court’s Recent Non-Action on Patent-Eligible Subject Matter, March 2, 2020
• Foreign Filing License Requirements in the United States and Abroad, Hamilton Brook Smith Reynolds, August 10, 2018

• David M. Habib Joins Hamilton Brook Smith Reynolds Life Science Team more